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Abstract
Background Whilst research and innovation is embedded within the UK’s National Health Service (NHS) constitution,
Doctors-in-training have little opportunity to contribute to designing, leading and recruiting into clinical trials or cohort
studies. We formed the West Midlands Collaborative Ophthalmology Network for Clinical Effectiveness & Research by
Trainees (The West Midlands CONCERT) and undertook a characterisation of post cataract surgery endophthalmitis as a
proof-of-concept study to test the feasibility of the CONCERT model.
Methods Doctors-in-training formed a collaborative working group to test the concept of delivering a pan-regional clinical
effectiveness study across multiple hospital sites by performing retrospective analyses of post cataract endophthalmitis over
a 6-year period.
Results Overall, 157,653 cataract surgeries were performed by participating centres accredited to deliver the Royal College
of Ophthalmologists training curriculum. Thirty-eight cases of post cataract endophthalmitis were identified, giving an
incidence of 2.41 per 10,000 cases (0.0241%). A further 15 endophthalmitis cases presented who had surgery in non-training
centres, giving a total of 53 cases. The most common organisms were S. epidermidis (14 (51.9%)) and P. aeruginosa (5
(18.5%)). Anterior-chamber and vitreous sampling yielded positive culture in 33.3% (6/18) and 50.9% (27/53), respectively.
At 6 months follow-up, 19 (51.4%) patients achieved visual acuities of ≤0.5 LogMAR. Repeat intravitreal injections (11
(20.8%)) and vitrectomy (n= 22 (41.5%)) were not associated with better outcomes.
Conclusions Using post cataract endophthalmitis as a pilot cohort, this study highlights the feasibility of using the CON-
CERT model for studies across multiple sites. A UK-CONCERT could provide a powerful infrastructure enabling char-
acterisation of patient cohorts and a platform for high-quality interventional studies, improving patient care.
Introduction
The Health and Social Care Act 2012 states that research
and innovation is embedded into the National Health Ser-
vice (NHS) constitution [1]; Doctors-in-training are rarely
involved in designing, leading and recruiting in studies. In
the United Kingdom, Health Education England (HEE),
NHS Education for Scotland (NES), Health Education and
Improvement for Wales (HEIW) and Northern Ireland
Medical and Dental Training Agency (NIMDTA) are
responsible for implementing specialty training in accor-
dance with General Medical Council approved specialty
curricula. The Royal College of Ophthalmologists
(RCOphth) is responsible for setting the curriculum and
standards for ophthalmic specialist training, spanning seven
years, delivered through nineteen local units—13 HEE, 4
NES, 1 HEIW and 1 NIMDTA (Supplementary Fig. 1).
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HEE West Midlands (WM) hosts one of the largest Post-
graduate Schools of Ophthalmology with 60 trainees (9% of
UK trainee ophthalmologists), including 2 medical oph-
thalmology trainees, distributed across 14 out of a potential
19 hospital sites across the region [2]. The WM has an area
of 13,000 square kilometres with a population of 5.75
million (11% of the UK total) making it one of the most
densely populated regions in the country.
The National Institute for Health Research offers an
Integrated Academic Training (IAT) Programme to support
individuals to gain research experience as part of their
clinical training in the form of Academic Clinical Fellow-
ships (ACFs) and Clinical Lectureships (CL). A highly
competitive recruitment programme enables trainees to
integrate research time within their weekly timetable to
develop academic skills and research proposals for higher
degrees (ACFs), or they establish themselves as clinician
scientists following award of a higher degree (CL). Trainees
who are not part of the IAT gain experience in research
methods and clinical effectiveness projects within time
dedicated to research and audit within their weekly time-
table (~4 h per week) with additional time garnered through
study leave (maximum 5 days per year). Due to the geo-
graphical rotational nature of the training programme deli-
vering high-impact quality research for non-IAT trainees is
limited as the ability to complete long-term meaningful
projects is compromised.
Taking precedent from a number of successful trainee
networks such as Research & Audit Federation of Trainees
(RAFT, a national body of trainee anaesthetists), and West
Midlands Research Collaborative (WMRC) the surgical
trainee network that delivered the Reduction Of Surgical
Site Infection using a Novel Intervention (ROSSINI) Trial
[3], trainees from HEEWM Postgraduate School of Oph-
thalmology formed a network to work collaboratively to
deliver pan-regional clinical effectiveness studies, retro-
spective and prospective interventional research. Desig-
nated the West Midlands Collaborative Ophthalmology
Network for Clinical Effectiveness & Research by Trainees
(The West Midlands CONCERT), endophthalmitis follow-
ing cataract surgery was chosen by The CONCERT as a
pilot study to test the feasibility of gathering data across
multiple hospital sites.
Cataract Surgery is the most common surgical procedure
undertaken in the NHS, with 400,000 operations performed
per annum in England [4]. A sight-restoring procedure, the
most feared complication is post-operative endophthalmitis
which is sight threatening. According to the Endophthal-
mitis Vitrectomy Study Group, only 33% of patients
achieve a visual acuity (VA) of 6/12 (LogMAR equivalent
0.3) or better [5, 6]. The incidence of endophthalmitis in a
meta-analysis predominantly analysing published data from
the UK and USA declined from 0.327% in the period
1970–1980 to 0.158% in the period 1990–2000 and then
increased to 0.265% for the period 2000–2003, postulated
to be due to increased practice of sutureless clear corneal
incisions [5]. This frequency is substantially higher than the
0.033–0.11% reported in large tertiary referral centres and
small to medium more rural hospitals in China between
2011 and 2013, respectively [7]. This difference was found
to be related to posterior-capsule rupture rate, the use of
povidone iodine and intra-cameral (IC) antibiotic use.
Management of endophthalmitis is resource and time-
intensive [8]. The standard of investigation and treatment is
immediate aqueous and vitreous sampling followed by
intravitreal injection of broad-spectrum antibiotics [9].
There is no standardised guidance on the choice of intrao-
perative antibiotic prophylaxis for cataract surgery and this
differs between centres and between surgeons [10]. Within
the WM for example, a combination of IC or sub-
conjunctival (SC) cefuroxime and/or gentamicin injection
with or without corticosteroid, followed by post-operative
topical eye drop antibiotics for varying periods of time is
used. The national cataract audit has provided a defining
incidence of post cataract endophthalmitis in the UK, 43/
145,868 (0.03%) derived from data provided by partici-
pating centres between August 2007 and November 2010.
There are limited data in the UK on whether best endoph-
thalmitis treatment involves a single intravitreal injection or
sequential intravitreal injections of antibiotics a few days
apart, as advocated by recent studies [11, 12].
In this proof-of-concept feasibility study, the WM-
CONCERT was established to demonstrate collaborative
data assimilation for the characterisation of post cataract
endophthalmitis: its incidence, nature of samples taken,
microbiological yield, intraoperative antibiotics adminis-
tered, prevalence of antibiotic resistance and clinical out-
comes including VA, using a large cohort of cataract
surgeries performed over a 6-year period by ophthalmology
units across the WM region.
Methods
Establishing the collaborative network and data
handling
Doctors-in-training (Residents) from the HEEWM formed a
collaborative working group by inviting NHS Trusts
accredited to deliver the Royal College of Ophthalmologists
training curriculum to join the West Midlands CONCERT
network. Each participating hospital was assigned a lead
doctor-in-training and consultant. For larger hospital con-
sortia comprising several hospital sites, a lead consultant
and trainee were identified for each of the training hospital
sites. In order to test the feasibility of delivering a
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pan-regional clinical effectiveness programme, the project
protocol was approved by the Clinical Effectiveness
Department within each Hospital Trust. Data were captured
in validated study-site record forms with anonymised
patient and centre unique identifiers. Merging and cleaning
of data from each site were handled in accordance to the
tenets of General Data Protection Regulations. The project
data monitoring, steering and writing committee comprising
the overall Lead Consultant for the WM-CONCERT (SR)
and six trainees (GM, HB, IR, GB, AN and RB) met
quarterly to assess progress, milestones, risks, mitigation
steps, interim analyses and critical endpoints.
Testing the CONCERT Model: prevalence of post
cataract surgery endophthalmitis
In order to test the feasibility of the CONCERT model, the
steering committee considered high volume of cases and
rare intervention or complication as two essential inclusion
criteria for its inaugural retrospective pilot project. A cohort
study to analyse adult cases of post cataract endophthalmitis
over a 6-year study period (Jan 2010–Dec 2015) fulfilled
these criteria. A wide period of interest was required in
order to capture a meaningful number of cases of what is a
rare surgical complication. Surgical technique did not
evolve substantially during this time. Data collection was
between February and December 2018: this enabled ade-
quate follow-up data on clinical outcomes, and report best
final visual outcome.
Thirteen NHS Trusts (hubs) served 23 spoke hospitals
across the WM performing cataract surgeries. Eleven units
were excluded from the study either because they were non-
training private healthcare providers (n= 6), non-accredited
training units (n= 4) and a dedicated Children’s Hospital (n
= 1 (study cohort >18 years age)). A further two training units
elected not to participate. The remaining 11 ophthalmology
training units provided total numbers of cataract surgery
performed during the study period.
Microbiology data and visual outcomes analysis
Each participating hospital was assigned a lead doctor-in-
training and consultant for the project. To ensure as complete
capture as possible of endophthalmitis cases, we explored
various methods to identify previous cases. These included:
● Official trust audit data of endophthalmitis cases.
● Microbiology database of all vitreous and aqueous
samples analysed.
● Local endophthalmitis logbooks when available.
● Discussion with consultants regarding their post-
operative endophthalmitis patients
The doctor-in-training contacted the local microbiology
department, and cases were identified by screening all
aqueous and vitreous samples passing through micro-
biology departments. Cases of post-operative endophthal-
mitis other than cataract surgery, endogenous
endophthalmitis and pan-uveitis cases were excluded.
Clinical data were extracted from electronic and paper
records. Of these four mechanisms to capture endophthal-
mitis cases, we found the microbiology database the most
complete and captured all cases identified by other methods.
As all presumed cases of post-operative endophthalmitis
would have vitreous sampling ± aqueous sampling as part of
the work up, it is possible to have a high level of confidence
that all cases of endophthalmitis presenting to the hospitals
participating in the study were recorded.
The CONCERT collected data from the surgical unit that
performed the cataract surgery and the unit to which the
patient presented, including the acute presentation, intrao-
perative details, initial and subsequent treatments together
with investigations undertaken and microbiology results.
Several units did not have a dedicated emergency service
for Ophthalmology emergencies and referred cases to the
regional tertiary centre through a hub-and-spoke arrange-
ment for the provision of emergency care (Supplementary
Fig. 2A). For such patients, coordination by the CONCERT
was critical in obtaining pre-operative and intraoperative
data from the spoke surgical unit and aligning it with data
relating to the endophthalmitis episode at the tertiary
referral centre (Supplementary Fig. 2A, B). These included
units that do not have trainees. Microbiology, presentation,
and treatment data was available for 53 cases included in
the analysis that presented to tertiary hub referral centres.
Statistical analysis
Each participating centre recorded source data in a validated
study-site spreadsheet (Supplementary File 1) generated in
Excel® (Microsoft Corporation, Redmond, WA). Data from
each study-site spreadsheet were imported into a study
master-spreadsheet which amalgamated data from all par-
ticipating sites and enabled both preliminary descriptive
analyses as well as data export to IBM SPSS Statistics for
Windows, Version 25.0 (IBM Corp, Armonk NY) for sta-
tistical analysis, significance defined as p < 0.05. Prior to
analysis, continuous variables were assessed using the
Shapiro–Wilk test, and found not to be normally distributed.
Hence, data are primarily reported as medians and inter-
quartile ranges (IQRs) throughout. A Levene analysis
showed no significant difference in variance in groups being
compared. Mann–Whitney U and Wilcoxon signed rank
tests were used for un-paired VA data and two-paired VA
data, respectively. Fisher exact test was used for nominal
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variables. Bonferroni correction is applied for multiple
statistical analysis. Best corrected VA was used; where
records were in Snellen, conversion to LogMAR was
undertaken. For lower VA, corresponding to count fingers
(CF), hand movements (HM), perception of light (PL) and
no PL (NPL) were substituted with 2.10, 2.40, 2.70 and
3.00 LogMAR, respectively, in keeping with previous




Overall, 157,653 cataract surgeries were performed by
participating centres during the study period. A breakdown
of which units were included is available in Supplementary
Figs. 2A, B. Thirty-eight cases of post cataract endoph-
thalmitis were identified, giving an incidence of 2.41 in
10,000 cases (0.0241%). A further 15 endophthalmitis cases
presented who had surgery performed in non-training cen-
tres, giving a total of 53 cases.
Patients presented at median 6.50 (IQR 3.4–15.0). One
patient presented at 744 days, having been treated for
chronic non-resolving and progressive pan-uveitis since
surgery, later diagnosed as a chronic fungal endophthal-
mitis. Vitreous sampling was performed as per local hos-
pital practice, with 21G or 23G needle immediately before
administration of antibiotics. In two units, this was per-
formed utilising a single port vitrector with antibiotics
delivered at the end of the procedure. Aqueous sampling
was performed utilising an insulin syringe.
Clinical utility of culture data
During the study period, no endophthalmitis management
protocol involved repeat sampling or repeat intravitreal
antibiotics. Despite this, 11 (17.3%) had repeat intravitreal
injections. One (1.9%) patient was reinjected without
positive growth/sensitivity data, with amphotericin B for
presumed fungal infection.
Detection rates and Investigations microbiological
sampling
No cases had organisms detected in aqueous or by PCR that
were not also detected in vitreous. In 15 cases both aqueous
and vitreous cultures were sent. In ten cases, vitreous cul-
tures were positive, of which six also had positive aqueous
cultures (p= 0.275, Fisher’s Exact test). In seven patients,
vitreous fluid was sent for both PCR and culture. Of these
seven, three patients were both PCR and vitreous culture
positive demonstrating good concordance between PCR
detection and vitreous culture. These results are shown in
Table 1.
Bacteriology
Positive cultures and antibiotic sensitivity were obtained in
27/53 (50.9%) cases (Table 1). The most common organism
was Staphylococcus epidermidis (14 (51.9%)) followed by
Pseudomonas aeruginosa 5 (18.5%) and one case (3.7%)
each of Candida parapsilosis, Serratia marcescens, Strep-
tococcus haemolyticus, Serratia liquefans, Methicillin-
Resistant Streptococcus aureus, Streptococcus ovis, Strep-
tococcus pneumoniae and Streptococcus parasanguinis.
Antimicrobial use and reporting
Supplementary Table 1 shows antimicrobial/classes of
antibiotic reporting of sensitivities for intravitreal injections/
systemic and topical augmentation, those with clinical
implication in endophthalmitis highlighted with an asterisk.
The most common antibiotic used intraoperatively during
cataract surgery was cefuroxime; sensitivity was reported in
two cases, both of which were resistant. The most common
systemic antibiotic used was ciprofloxacin used in 36
(67.9%) cases. Of the 27 patients with positive growth,
ciprofloxacin sensitivity was reported in 15 (55.6%) cases,
Table 1 Investigations and
results.
Investigation performed Samples sent n (%) Positive yield for each investigation
n/total (%):
Aqueous Vitreous PCR
Vitreous culture only 31 (58.5) – 15/31 (48.4) –
Both AC and vitreous culture 15 (28.3) 6/15 (40.0) 9/15 (60.0) –
Vitreous culture and vitreous PCR 4 (7.6) – 2/4 (50.0) 2/4 (50.0)
AC and vitreous culture and vitreous PCR 3 (5.7) 0/3 (0.0) 1/3 (33.3) 1/3 (33.3)
Total 53 (100.0) 6/18 (33.3) 27/53 (50.9) 3/7 (42.8)
Detection rates from vitreous, aqueous and PCR investigation.
PCR polymerase chain reaction, AC anterior chamber.
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of which 6 (22.2%) were resistant. On subgroup analysis
where ciprofloxacin sensitivity was reported, resistance was
found in 6/15 (40.0%). For S. epidermidis, resistance to
ciprofloxacin was demonstrated in 5/9 (55.6%) cases. One
case of S. epidermidis, demonstrated vancomycin resis-
tance, and another had intermediate sensitivity to vanco-
mycin. Both cases were gentamicin sensitive, and one
ciprofloxacin resistant. Cephalosporin sensitivity was not
reported in either of those cases.
Visual acuity (VA)
Apart from one case, all patients presented prior to their first
follow-up visit and as such no post-surgery objective VA
was available. Patients presented with a subjective reduction
of vision from post-surgery. Six-months VA was available
in 37/53 (69.8%) patients. Missing data were due to patients
lost to follow-up, incomplete transference of data to elec-
tronic records, follow-up in private clinics/non-training
hospitals and 2 (3.7%) patients deceased during the period.
VA for the whole cohort (Fig. 1a, f) and for subgroup
analysis (Fig. 1b–f) are reported across different time
points. Paired VA data at different time points are reported
in Fig. 2a, b. Positive vitreous culture (Fig. 1b, f) and the
need for repeat intravitreal antibiotics (IVI) (Fig. 1e, f) had
worse visual outcomes at 6 months. A growth of S.
epidermidis infections demonstrated better VA outcomes
compared to other microbes (Fig. 1c, f).
Patients requiring vitrectomy had a worse pre-operative
VA (Fig. 1d) with vitrectomy being performed in 22
(41.5%) of patients (7 (41.2%) <24 h; 15 (70.5%)
<2 weeks). At 6 months, whilst 50% of all patients achieved
VA ≤ 0.5 (Fig. 2a), vitrectomy was not associated with
better visual outcomes (Fig. 1d, f).
Discussion
This study highlights that the CONCERT model has the
potential to deliver outcomes from a pan-regional data
collection initiative across multiple sites. Taking as a pre-
cedent RAFT and WMRC, the WM-CONCERT has
demonstrated an ability to bring together individual hospi-
tals, share and analyse data with the ultimate aim of stan-
dardising patient care across the region and to provide an
infrastructure for high powered multicentre interventional
trials. Working within the network, the CONCERT was
able to simultaneously access patient records and data
across 15 different sites and feed into a master-file to effi-
ciently generate descriptive and more meaningful statistics
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Fig. 1 Visual outcomes and subgroup analysis, Box and Whisker
plot. ‘X’ denotes mean. Hash symbol ‘#’ denotes Mann–Whitney U
test; plus symbol ‘+’ denotes Wilcoxon Signed Rank Test. An asterisk
‘*’ denotes Fishers Exact test. Bonferroni critical p value 0.017 (a–e),
0.05 (f). Statistical significance in bold. a Representation of all
patients’ visual acuity. b Difference in visual acuity between patients
that had a positive culture on vitreous biopsy compared to no growth.
c Vision in patients that had S. epidermidis growth vs. other microbes.
d Vision in patients that underwent vitrectomy vs. no vitrectomy. No
significance was seen at all time frames. e Vision in patients that had
additional intravitreal injection (IVI) of antibiotic vs. those that did
not. f Subgroup analysis (Fisher’s Exact test) at 6 months visual acuity
of patients achieving 0.6 LogMAR or better visual acuity.
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Although there are many advantages to a collaborative
network such as the CONCERT, there were two key hurdles
that were encountered. First, the Excel spreadsheet was
useful for this feasibility study for local site data entry in the
context of low sample size (such as endophthalmitis cases)
as it allowed multicentre site files to be exported and
merged into a trial master excel file. Nevertheless, usability
is limited for larger sample sizes and for complex rando-
mised controlled studies across many sites regionally or
nationally. The second hurdle related to the curriculum-
driven rotation of Trainees across the region to various sites.
Delays in handover by the outgoing trainees to the incom-
ing trainees led to periods of natural suspension before data
collection resumed. To overcome this, the CONCERT is
integrating browser-based technology in its methodology
using Research Electronic Data Capture (REDCap® Van-
derbilt University), a software workflow system for
designing clinical and translational research databases. This
is a centralised web-based database with mobile device
application tokens for lever date entry that will significantly
simplify the data collection process as it enables direct
continuity between patients that were transferred across
different trusts, and between rotating trainees. This system
is being used widely to enhance consortia and the delivery
of collaborative research through international research
networks and has recently been adopted by WMSRC.
Embedding a browser-based data workflow package will
provide a sound infrastructure for the WM-CONCERT to
work with other regional CONCERTs across the country to
deliver a UK-CONCERT to support high-impact investi-
gator led clinical trials.
The CONCERT data for this feasibility study provided
an overall rate of post-phacoemulsification endophthal-
mitis across 11 treatment centres as 2.41 per 10,000 cases.
Table 2 [13–20] presents the incidence of endophthalmitis
found in this study in comparison with other studies of
post-operative endophthalmitis. As a multicentre study,
we included a broader range of surgical techniques and
peri- and post-operative antimicrobial prophylaxis
regimes than single-centre studies and therefore provide a
more representative estimate of overall incidence. In all
the studies, the large majority of cataract operations were
carried out by phacoemulsification. The UK NOD audit,
reported by Donachie et al., is included to give a national
perspective across England and Wales. It is notable
however that 22.7% of operations lacked recorded post-op
data in this cohort, and that the rate of endophthalmitis
was not a primary outcome measure for the audit [13]. A
great advantage of a national database is that it can give a
nationwide view of surgical complications, and the NOD
captured ~20% of cataract surgeries performed during its
data collection period and report 65% reporting of post-
operative VA data. As the NOD primary aim was to report
risk adjusted rates for PCR and VA loss in cataract sur-
gery, there was no microbiology data reported for
endophthalmitis cases [13]. In our study, we estimate that
we captured 65% of cataract surgeries performed in the
region. This was achieved by using NOD report 4
(appendix 7) to estimate number of surgeries performed
per year, in units we did not have surgical numbers for
[21]. We report microbiology sensitivities in 53 (100%) of
cases and 6-month VA data in 37 (70%) of cases.
+p<0.001 p=0.098 p<0.001 p=0.002 p=0.279
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Fig. 2 Comparing paired visual acuity of patients at different time
points. *Wilcoxon Signed Rank Test, Bonferroni critical p value 0.05
(a), 0.01 (b). Statistical significance in bold. a Scatterplot of paired
presentation vs. 6-month VA. Median VA 0.5: 50% of patients
achieved vision equal or better than 0.5 LogMAR. b Box and Whisker
plot of paired VA LogMAR units gain at different time points. ‘X’
denotes mean.
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Our study however has the considerable advantage of
associated microbiology data with cases of endophthalmitis,
as well as including a greater number of cataract operations
due to the longer window for data collection.
There is an apparent reduction in the rate of endoph-
thalmitis following phacoemulsification surgery over time
(Table 2), perhaps due to increasing use of IC cefuroxime
prophylaxis [15]. Mollan et al. reported post cataract
endophthalmitis between 1996 and 2004 from Birmingham
Midland Eye Centre (UK). This is a regional tertiary referral
centre also included in our study. In Mollan et al.’s data set
endophthalmitis case referrals originated from 13 operating
suites, and they reported an incidence of 0.099% (i.e. almost
1 per 1000 cases) over an 8-year period [20]. Extracting
data from the CONCERT dataset for the same participating
sites, we report an incidence of 0.0179% (15 out of 83,867
cases i.e. 1.7 per 10,000 cases over a 6-year period)
demonstrating a substantial reduction in incidence. Being a
retrospective case series, some of the analyses were
restricted by this inherent study design limitation. For
example, we could not compare SC to IC antibiotics rate of
endophthalmitis; even within units that a principle change
in practice from SC to IC took place, interdepartmental
variability in practice, between clinicians, persisted.
We present 53 cases of post-phacoemulsification
endophthalmitis, of which 26 (50.9%) yielded positive
microbial culture from either vitreous culture alone or
vitreous plus aqueous culture. This represents the largest
cohort of patients evaluated in the UK to date. There was no
case in this series where an aqueous sample gave a positive
culture and a vitreous sample did not. Conversely, in four
cases a positive vitreous culture was accompanied by a
negative aqueous culture from the same patient, suggesting
that aqueous culture has poorer sensitivity. These findings
are in keeping with both studies in animal models [22] and
those previously reported in clinical studies showing aqu-
eous tap culture-positive rates in 20–37.7% of clinically
diagnosed endophthalmitis cases compared to 48.8–74% of
vitreous samples [23, 24]. Despite overall greater sensitivity
of vitreous cultures, some studies report the occasional
aqueous sample culture showing pathogenic microorganism
growth (rather than contaminant) where a corresponding
vitreous sample culture is negative [25, 26].
The results presented here support the use of vitreous tap
culture in clinically identified cases of post-operative
endophthalmitis. Although there was a 49.1% culture-
negative rate provided on average 72 h after sampling,
indicating the need for more specific rapid molecular
diagnostics or better optimisation of laboratory culture
protocols to yield improved positive identification of cau-
sative organisms. In addition, while we recognise the rela-
tively small numbers of aqueous samples taken in this
study, consideration should be given to whether aqueous
taps are required in all cases of endophthalmitis given the
low likelihood of aqueous sampling providing additional
useful diagnostic information to vitreous tap. While VA was
significantly better at 6 months follow-up compared to
presentation; pre-operative VA was significantly better than
both presentation and final VA. Post-surgical VA was not
available as not all patients had had their first post-operative
Table 2 Endophthalmitis rates in reported adult case series.






This study (2019) 2010–2015 West Midlands, UK 157,653 37 (0.025%) Retrospective cohort
Donachie et al.
(2016) [13]
2014–2015 UK 75,827 14 (0.018%) National Ophthalmology Database (NOD)
Audit Retrospective, cross sectional study




2005–2014 France 6,371,242 6668 (0.105%) Retrospective cohort, cases up to 6 weeks
post-op
Nam et al. [16] 2006–2009 Gyeongsangnam-do and
Pusan city, South Korea
192,747 71 (0.037%) Retrospective, cross-sectional study
Lundström et al. [17] 2002–2010 Sweden 692,786 244 (0.035%) Retrospective cohort
Hatch et al. [18] 2002–2006 ON, Canada 442,177 617 (0.140%) Retrospective cohort
Montan et al. [19] 1998 Sweden 54,666 58 (0.100%) Prospective study, follow-up to 2 years
post-op
Mollan et al. [20] 1996–2004 Birmingham, UK 101,920 105 (0.103%) Retrospective cohort
Multicentre studies of incidence. All figures reported post cataract endophthalmitis. Creuzot-Garcher et al. [15] specify all cases are
phacoemulsification. Inoue et al. [14], were 99.4% phaco, 0.5% ECCE, 0.1% ICCE. The other series do not explicitly specify operating
technique, but majority of cases are presumed phacoemulsification from the years of data collection. No one method of antibiotic prophylaxis
was used; generally, a mixture of intra-cameral, subconjunctival and topical depending on the operating surgeon/institution.
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visit. Vitrectomy had no effect on visual outcome, although
culture-positive cases seemed to indicate poorer prognosis.
Post-operative endophthalmitis is thought to be most
commonly caused by the intra-ocular inoculation of the
patient’s bacterial flora [27]. Gram-positive organisms were
the most prevalent in the cohort presented here, S. epi-
dermidis was identified in 53.8% of culture isolates. The
spectrum of causative organisms in this study is largely
consistent with previously published data [28–30]. Geo-
graphical variability is recognised, with one study from
Taiwan demonstrating Enterococcus faecalis as marginally
more common bacterium than S. epidermidis [31]. Fungal
species are rare causes of post-surgical endophthalmitis in
temperate regions [28, 29, 32]. A recent study on virulence
of S. epidermidis by Chiquet et al. [33]. demonstrated that
strains that caused endophthalmitis differed from those that
did not. More virulent strains had an increased likelihood of
carrying genes coding for adhesion and biofilm formation
and also had increased antibiotic resistance. However,
numerous studies have shown that patients with S. epi-
dermidis endophthalmitis have better visual outcomes
compared to those patients with Enterococcus [31], S.
aureus and gram-negative bacteria [34]. Our study con-
firmed this; patients with S. epidermidis endophthalmitis
have significantly better presenting visual acuities and better
6-month post-presentation VA compared to those that grew
other micro-organisms.
Initial treatment for endophthalmitis is empirical. Typical
antimicrobial agents used are vancomycin providing
excellent Gram-positive coverage, and ceftazidime or ami-
kacin for Gram-negative coverage. Antibiotic sensitivity
data from our cohort shows most Gram-positive organisms
were sensitive to vancomycin; however, one isolate of S.
epidermidis was resistant. Many other published studies
suggest almost universal vancomycin sensitivity amongst
Gram-positive bacteria [28, 31, 32], with only very sporadic
resistant cases [29, 30]. A recent retrospective study of
endophthalmitis cases from a patient population geo-
graphically close to our cohort showed 100% Gram-positive
bacterial sensitivity to vancomycin [35]. The potentially
devastating impact of vancomycin resistance in these
organisms should prompt careful monitoring of bacterial
resistance patterns. Cefuroxime is the most common anti-
biotic used intraoperatively in our region, but sensitivity
was reported in just two cases with resistance in both,
highlighting a potential future problem with resistance. The
most common systemic antibiotic used for the management
of endophthalmitis in this cohort was ciprofloxacin (66.7%
of cases). From our data, where ciprofloxacin sensitivity
was reported, there are high resistance rates for a first line
antibiotic (40.0%). Systemic moxifloxacin has been shown
to have ocular penetration than ciprofloxacin, potentially
underlying its great efficacy [36].
There was little standardisation of microbiological sensi-
tivity reporting for ophthalmic infections in this cohort, with
vancomycin, cephalosporin and aminoglycoside sensitivity
reported in just (51.8%), 5 (18.5%) and 20 (74.1%) of cases
respectively (Supplementary Table 1). Given the standardisa-
tion of treatment, especially initial therapy, it would be bene-
ficial for microbiology laboratories to standardise their
sensitivity testing for intra-ocular culture samples with appro-
priate antibiotic panels. In particular, testing for cefuroxime
sensitivity should be undertaken routinely given its widespread
use as prophylaxis. Classically microscopy, culture and sen-
sitivity has been the gold-standard in identifying pathogens in
endophthalmitis. However, this presents challenges in an
ophthalmology setting, with relatively low sensitivities from
aqueous and vitreous samples and the time-consuming nature
of these investigations delaying more tailored treatment. There
has been increasing evidence that real-time PCR may be
beneficial when performed alongside more established meth-
ods. Therese et al. [37] demonstrated that positive specimens
increased by 29.3% when PCR was used in addition to
microscopy and culture. In addition, a study by Tarai et al.
looking at fungal endophthalmitis showed PCR sensitivity of
50% and specificity of 100% [38]. Many studies have also
demonstrated that PCR is a useful tool when cultures are
negative (Table 3) [39–43]. There has however been a reported
14% false positive rate of PCR [44]. This may limit its use to
cases where culture is negative, and another method is required
to identify pathogens. In our cohort, PCR had a comparable
sensitivity to vitreous culture; seven cases had both investi-
gations and results were concordant in all seven.
Overall, we report a post-phacoemulsification endoph-
thalmitis incidence comparable to previous studies. Micro-
bial culture remains key to organism identification, and
culture from vitreous tap may be more sensitive than aqu-
eous tap. Gram-positive bacteria were the main causative
organisms. Resistance to commonly used antibiotics, par-
ticularly vancomycin and ciprofloxacin, are of concern and
it is vital that ophthalmology departments regularly audit
sensitivity data from infecting organisms to determine the
most appropriate empirical antibiotics for local bacterial
antibiotic resistance patterns. Close collaboration between
ophthalmic and microbiology departments may enable use
of standardised ophthalmic antibiotic sensitivity reporting.
Analysing our data geographically and chronologically did
not reveal any geographic clusters or changing bacterial
sensitivity over time. A UK wide national CONCERT may
be required to demonstrate this.
In summary, the CONCERT model has facilitated the
delivery of a retrospective region-wide descriptive study of
post-surgical endophthalmitis. We provide a regional inci-
dence of the most feared complication of cataract surgery in
the largest published UK dataset to date. Progression to pro-
spective longitudinal phenotyping studies using a web-based
G. Moussa et al.
and mobile device data capture system is currently underway.
The WM-CONCERT, working in partnership with other
regional CONCERTS, has the scope to develop and deliver
collaborative projects of complex design. A UK-CONCERT
could provide an infrastructure to characterise national cohorts
and implement interventional studies of novel therapeutic
technologies, to standardise and deliver better clinical out-
comes and improve patient care.
Summary
What was known before
● Management of endophthalmitis is resource and time-
intensive, and there is no standardised guidance on the
choice of intraoperative antibiotic prophylaxis for
cataract surgery.
● Regional variation exists between centres and between
surgeons, in methods of acquiring microbiological
samples and use of microbiology sensitivity and
resistance panels.
What this study adds
● Ophthalmology doctors-in-training formed the West
Midlands Collaborative Ophthalmology Network for
Clinical Effectiveness & Research by Trainees (The
West Midlands CONCERT), working across the region
to produce the largest published UK dataset of post
cataract endophthalmitis and showing an incidence of
2.41/10,000 surgeries (0.0241%).
● A collaborative approach to data gathering means our
multicentre CONCERT study estimate of the incidence
of endophthalmitis following cataract surgery is likely to
be representative of the wider population.
● Partnering with other regional CONCERTS and forming
a UK-CONCERT has the potential to deliver impactful
projects including phenotyping of national cohorts and
undertaking complex interventional studies with the aim
of improving patient care.
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Table 3 Previous studies of polymerase chain reaction (PCR) in post cataract endophthalmitis.








This Study 7 Vitreous 0 0 3 4
Joseph et al. [39] 64 Vitreous 1 19 18 26
Lohman et al. [40] 25 Aqueous 0 21 0 4
Lohman et al. [40] 25 Vitreous 0 17 6 2
Lohman et all. [41] 16 Aqueous 0 15 1 0
Lohman et all. [41] 16 Vitreous 0 7 7 2
Chiquet et al. [42] 30 Aqueous 2 9 6 9
Sowmya et al. 2009* 72 Aqueous 3 32 24 13
Sownya et al. 2009* [43] 72 Vitreous 2 40 25 5
An asterisk denotes post cataract, post traumatic and endogenous endophthalmitis.
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